GKHT Medical Technology Past Earnings Performance
Past criteria checks 4/6
GKHT Medical Technology's earnings have been declining at an average annual rate of -1.1%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 8.3% per year. GKHT Medical Technology's return on equity is 6.7%, and it has net margins of 2.3%.
Key information
-1.1%
Earnings growth rate
-5.6%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 8.3% |
| Return on equity | 6.7% |
| Net Margin | 2.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Why GKHT Medical Technology's (SZSE:301370) Earnings Are Better Than They Seem
Nov 04
Shareholders Will Be Pleased With The Quality of GKHT Medical Technology's (SZSE:301370) Earnings
May 01Recent updates
Why GKHT Medical Technology's (SZSE:301370) Earnings Are Better Than They Seem
Nov 04Earnings Not Telling The Story For GKHT Medical Technology Co., Ltd. (SZSE:301370) After Shares Rise 31%
Oct 01GKHT Medical Technology Co., Ltd.'s (SZSE:301370) Popularity With Investors Is Under Threat From Overpricing
Aug 14Investors Could Be Concerned With GKHT Medical Technology's (SZSE:301370) Returns On Capital
Jul 17These 4 Measures Indicate That GKHT Medical Technology (SZSE:301370) Is Using Debt Reasonably Well
Jun 07Shareholders Will Be Pleased With The Quality of GKHT Medical Technology's (SZSE:301370) Earnings
May 01Revenue & Expenses Breakdown
How GKHT Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 7,201 | 163 | 435 | 12 |
| 30 Jun 24 | 7,266 | 151 | 463 | 12 |
| 31 Mar 24 | 7,430 | 155 | 493 | 12 |
| 31 Dec 23 | 7,483 | 154 | 498 | 13 |
| 30 Sep 23 | 7,228 | 122 | 547 | 12 |
| 30 Jun 23 | 7,217 | 137 | 526 | 12 |
| 31 Mar 23 | 6,590 | 126 | 489 | 13 |
| 01 Jan 23 | 6,360 | 125 | 470 | 12 |
| 30 Sep 22 | 5,898 | 142 | 467 | 11 |
| 30 Jun 22 | 5,029 | 149 | 433 | 11 |
| 31 Mar 22 | 5,466 | 148 | 415 | 11 |
| 31 Dec 21 | 5,847 | 151 | 410 | 11 |
| 30 Sep 21 | 4,813 | 158 | 395 | 10 |
| 30 Jun 21 | 7,974 | 165 | 388 | 10 |
| 31 Mar 21 | 7,466 | 156 | 371 | 9 |
| 31 Dec 20 | 4,862 | 146 | 355 | 8 |
| 31 Dec 19 | 4,246 | 149 | 278 | 3 |
| 31 Dec 18 | 3,637 | 93 | 185 | 1 |
| 31 Dec 17 | 2,195 | 74 | 111 | 0 |
| 31 Dec 16 | 1,564 | 56 | 83 | 0 |
| 31 Dec 15 | 972 | 15 | 61 | 0 |
Quality Earnings: 301370 has high quality earnings.
Growing Profit Margin: 301370's current net profit margins (2.3%) are higher than last year (1.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301370's earnings have declined by 1.1% per year over the past 5 years.
Accelerating Growth: 301370's earnings growth over the past year (33.8%) exceeds its 5-year average (-1.1% per year).
Earnings vs Industry: 301370 earnings growth over the past year (33.8%) exceeded the Healthcare industry -5.7%.
Return on Equity
High ROE: 301370's Return on Equity (6.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 10:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GKHT Medical Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|